VAERS Explorer
Back to explore

Report #2869856

Received Oct 31, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Oct 16, 2025
Onset
Oct 1, 2025
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (3)

FatigueHeadachePyrexia

Symptom narrative

fever; Head pain/headache; Fatigue; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 16-OCT-2025, the patient received Shingles vaccine. In OCT-2025, less than a day after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever), headache (Verbatim: Head pain/headache) and fatigue (Verbatim: Fatigue). The outcome of the fever, headache and fatigue were not reported. It was unknown if the reporter considered the fever, headache and fatigue to be related to Shingles vaccine. It was unknown if the company considered the fever, headache and fatigue to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 17-OCT-2025 The batch number was not provided, and we are unable to contact the reporter.